VEL-101 to Prevent Rejection After Kidney Transplantation

Inclusion criteria

• . Greater than or equal to 18 years of age
• . Able to understand key components of the study as described in the written informed consent document and willing and able to provide written informed consent.
• . If female, surgically sterile (post hysterectomy, bilateral salpingectomy, or bilateral oophorectomy), postmenopausal (greater than 12 months of amenorrhea without alternative medical causes), or, if of childbearing potential, is using a highly effective contraception until 90 days after EOS visit.
• . If male, is vasectomized, has undergone bilateral orchidectomy, agrees to abstinence of heterosexual intercourse, or only has female partner using highly effective contraception, surgically sterile or postmenopausal and agrees to use method until 90 days after EOS visit.
• . Receiving kidney allograft from deceased donor or non-human leukocyte antigen (HLA) identical living donor.
• . Able \& willing to comply with all study procedures, including PK and PD assessments, as assessed by the Investigator
• . Vaccination up to date per the center's SOC as assessed by the Investigator.
• . In the opinion of the Investigator, is able to adhere to the study requirements.

Exclusion criteria